Spago Nanomedical AB Total Liabilities

Latest as of December 2025: Skr5.94 Million SEK ≈ $638.92K USD

Spago Nanomedical AB total liabilities. Based on the latest financial reports, Spago Nanomedical AB (SPAGO) has total liabilities worth Skr5.94 Million SEK (≈ $638.92K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SPAGO financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Spago Nanomedical AB (2011–2025)

Total liabilities of Spago Nanomedical AB from 2011 to 2025. This chart illustrates how Spago Nanomedical AB's total liabilities have evolved over time, based on quarterly financial data.

Spago Nanomedical AB Competitors by Total Liabilities

The table below lists competitors of Spago Nanomedical AB ranked by their total liabilities.

Company	Country	Total Liabilities
DecideAct A/S CO:ACT	Denmark	Dkr16.53 Million
Stelrad Group PLC LSE:SRAD	UK	GBX166.03 Million
Mobi724 Global Solutions Inc V:MOS	Canada	CA$15.11 Million
Dongwon Systems Corp KO:014825	Korea	₩701.13 Billion
Smiths News PLC LSE:SNWS	UK	GBX164.50 Million
SATO Technologies Corp V:SATO	Canada	CA$7.52 Million
Beam Communications Holdings Ltd AU:BCC	Australia	AU$3.61 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Spago Nanomedical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SPAGO current and non-current assets.

Liquidity & Leverage Metrics

Spago Nanomedical AB Total Liabilities Ratios Explained

Spago Nanomedical AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Spago Nanomedical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Spago Nanomedical AB (2011–2025)

The table below shows the annual total liabilities of Spago Nanomedical AB from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr5.94 Million ≈ $638.92K	-6.47%
2024-12-31	Skr6.35 Million ≈ $683.15K	-45.59%
2023-12-31	Skr11.67 Million ≈ $1.26 Million	+32.64%
2022-12-31	Skr8.80 Million ≈ $946.70K	+29.14%
2021-12-31	Skr6.81 Million ≈ $733.08K	+116.53%
2020-12-31	Skr3.15 Million ≈ $338.56K	+8.15%
2019-12-31	Skr2.91 Million ≈ $313.05K	-29.00%
2018-12-31	Skr4.10 Million ≈ $440.90K	+7.50%
2017-12-31	Skr3.81 Million ≈ $410.12K	-53.63%
2016-12-31	Skr8.22 Million ≈ $884.50K	-11.90%
2015-12-31	Skr9.33 Million ≈ $1.00 Million	-52.23%
2014-12-31	Skr19.53 Million ≈ $2.10 Million	-0.81%
2013-12-31	Skr19.69 Million ≈ $2.12 Million	+73.35%
2012-12-31	Skr11.36 Million ≈ $1.22 Million	-8.57%
2011-12-31	Skr12.42 Million ≈ $1.34 Million	--

About Spago Nanomedical AB

ST:SPAGO Sweden Biotechnology

Market Cap

$2.39 Million

Skr22.23 Million SEK

Market Cap Rank

#29813 Global

#673 in Sweden

Share Price

Skr0.03

Change (1 day)

-2.33%

52-Week Range

Skr0.03 - Skr0.14

All Time High

Skr19.04